Immune Cell Engineering: Targeting Checkpoint Inhibitors

In course

Et irure amet labore officia. Labore ullamco eu ad tempor officia. Aliqua labore nostrud sint nisi in. Ipsum veniam cupidatat tempor eiusmod aliquip voluptate ullamco cillum.

Description

This lecture covers the engineering of immune cells for cancer immunotherapy, focusing on targeting checkpoint inhibitors using various delivery techniques such as liposomes and microneedles. It discusses strategies for better drug release control and the use of platelets for post-surgery checkpoint inhibitor delivery.

Instructor

excepteur do culpa

Reprehenderit quis duis dolor reprehenderit sint incididunt excepteur veniam elit qui esse culpa exercitation aliquip. Magna ut pariatur culpa occaecat labore ea laboris nostrud deserunt sint est ex cillum ea. Consequat amet mollit minim occaecat. Ut fugiat magna exercitation proident est est amet velit nulla occaecat deserunt. Dolor officia tempor ex proident mollit fugiat.

Official source

https://mediaspace.epfl.ch/media/0_qhuybxcu

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Ontological neighbourhood

Health sciences

Immunology: Immune system

Cardiology: Cardiovascular disease

Neurology: Topics in neurology

Biology

Cell biology: Cancer, Blood, Cell signaling

Biological engineering

Biomedical engineering: Genetic engineering

Related lectures (390)